Answers are grounded in this paper and cite their sources.
The usage of biological drugs in autoimmune diseases treatment has significantly changed the clinical disease course especially for patients with particularly complicated or poor response to the treatment, demonstrating the ability to inhibit disease progression. Therefore, nowadays, biologics represent an increasing proportion of total pharmaceutical expenses despite differences in standard of routine care and high prices The articles presented in the Research Topic highlight the broad area of this subject. In this Research Topic, three reviews, a case report, a research report and an original research articles were published.
No takes yet. Share an insight, caveat, or question.
Wajda et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: